4th Quarter - Report
BROYDRICK & ASSOCIATES for EXELA PHARMA SCIENCES
Client
Income
$10,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
Drug shortages and FDA approval, USTR acceptance.
| Lobbyist | Covered position, as disclosed |
|---|---|
| WILLIAM B BROYDRICK | — |
| SAMANTHA DORSEY | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.